Helen of Troy (HELE) Q1 2027 earnings review
Sales Finally Grow Again — But Earnings and Cash Tell a Harder Story
After five quarters of decline, Helen of Troy's revenue reversed to +8.2% growth ($402.1M), with organic growth of +7.4% across both segments — the first clean quarter in five without an impairment charge. Management raised the full-year sales outlook. But the quality underneath is weak: adjusted EPS fell 58.5% to $0.17, operating cash flow turned negative (-$0.6M vs +$58.3M a year ago), and Beauty & Wellness adjusted operating income nearly halved. The headline GAAP EPS of $1.51 is almost entirely a $1.74 one-time gain from selling a distribution facility. With EPS guidance merely maintained, roughly 95% of the year's adjusted earnings now sit in the remaining nine months.
🐂 Bull Case
Organic growth turned positive in both segments (Home & Outdoor +8.8%, Beauty & Wellness +6.2%) after five quarters of decline, the sales outlook was raised, and no impairment charge was booked for the first time in five quarters. Sales and adjusted EPS came in above management's own expectations.
Total debt fell to $716M from $871M a year ago, helped by the $82M facility sale applied to debt. Interest expense declined 11%, and net leverage of 3.48x is on a stated path to 3.2x or lower by year-end.
🐻 Bear Case
Adjusted operating income was flat at $16.1M despite $30M more revenue — margin fell 30bps as tariffs, inventory obsolescence and customer mix ate the entire volume gain. Adjusted EPS dropped 58.5%, mostly on a normalized tax rate.
Operating cash flow swung from +$58.3M to -$0.6M, and free cash flow to -$6.4M. The full-year $85-100M free cash flow target now depends 100%+ on the remaining nine months, alongside ~95% of adjusted EPS.
⚖️ Verdict: ⚪
Neutral. The top-line inflection is real and the stabilization thesis got its first confirming datapoint. But part of the growth is easy comps, earnings power is flat at best, cash flow inverted, and the year's entire earnings and cash burden shifted into the back half. Good headline, unresolved substance.
Key Themes
Beauty & Wellness: Growing Sales, Collapsing Profitability
The datapoint that most contradicts the recovery narrative: B&W revenue grew 7.0%, yet adjusted operating income fell 48.2% to just $3.8M — a 1.8% margin, the segment's lowest in the five-quarter window. Excluding the facility-sale gain, the segment's underlying operating result was actually a small loss before addbacks. Tariffs, less favorable inventory obsolescence, and higher share-based compensation absorbed all the volume. Home & Outdoor moved the opposite way: adjusted operating income up 39.2% to a 6.3% margin. The two segments have swapped roles — B&W is now the profit laggard.
Operating Cash Flow Reversed to Negative
A classic red flag: net income was positive $35.8M while operating cash flow was negative $0.6M — moving in opposite directions. A year ago Q1 generated +$58.3M. Likely explanations: working capital absorption as the business restocks for growth (receivables up $9M YoY), and cash tariff payments — inventory now carries ~$15M of capitalized tariff costs. This matters more here than at most companies: the covenant-relief story, the 3.2x leverage target and the debt-paydown priority all run on cash. Q1 debt reduction ($65M) was funded by the facility sale, not operations.
The 8.2% Growth Is Comp-Flattered on Both Sides
Management disclosed this candidly, which deserves credit — but investors should size it. Home & Outdoor lapped a quarter where tariff uncertainty pulled retailer orders out of last year's Q1 into the prior Q4. Beauty & Wellness fan and thermometer sales lapped tariff-related direct import cancellations and China thermometry disruption. Last year's Q1 took roughly an 8-point tariff-disruption hit to revenue, so a meaningful slice of today's growth is mechanical recovery of lost shipments, not new demand. The cleanest underlying signals are Osprey international pack demand and nail care distribution gains.
Back-Half Concentration Got Heavier, Not Lighter
Last quarter management guided >80% of FY27 EPS into the second half and insisted it was comp math, not conservatism. Q1 delivered only $0.17 of a $3.25-$3.75 adjusted EPS year — about 5% of the midpoint — so ~95% now sits in the remaining nine months, versus ~88% at the same point last year. The remaining nine-month adjusted EBITDA requirement is $164-172M against $160.3M in the comparable prior-year period: achievable, but with zero cushion for a weak flu season, a consumer wobble, or tariff escalation.
Sales Raised, Profit Maintained = A Quiet Margin Guide-Down
The outlook raises sales but holds adjusted EPS, EBITDA and free cash flow flat — meaning management now expects lower margins on higher revenue. The stated culprits are new: rising commodity and energy costs from Middle East tensions (excluded as 'too new to model' last quarter, now embedded), unfavorable Chinese Yuan moves, higher freight, and costs to secure supply. The outlook also now includes a $9.2M one-time Phase 1 tariff refund inside 'maintained' EBITDA guidance — excluding it, the underlying profit outlook effectively slipped ~5%.
Nail Care Distribution Engine Keeps Running
Nail care (Olive & June) was again the named growth driver in Beauty & Wellness, powered by new and expanded distribution. The brand delivered 18% organic growth last quarter and ~$110M of FY26 revenue. The open question the release doesn't answer: how much of the growth is door-count expansion versus same-store velocity — the durability of this driver depends on the latter.
Osprey International Demand and New Product Launches
Home & Outdoor's +9.5% was led by strong international demand for technical, lifestyle and travel packs — Osprey holds the #1 US technical pack share and has been taking share in a declining category. New product launches contributed in both segments (the release cites incremental launch sales in packs and in Wellness), continuing the product-led innovation pivot begun under interim leadership: the VersaStyler, Osprey adjacent-category expansion, and Olive & June's gel system were the recent standouts.
Pricing Fully Landed With Retailers
Last quarter management said 'effectively 100%' of planned price increases — worth ~$50M of FY27 revenue — were accepted by retailers. Q1's growth with only modest gross margin erosion (-110bps despite tariffs) suggests early price realization is holding, and the outlook still assumes conservative elasticity. Consumer response through the higher-volume back half remains the test.
Macro: Pressured Consumer, Promotional Shelf, Volatile Inputs
Management's outlook assumes continued inflationary pressure, softness in discretionary categories, conservative retailer inventory management, and an increasingly promotional landscape. Illness incidence is assumed in line with the past three seasons — well below pre-Covid norms — a sensibly conservative base after last year's flu season 'didn't really happen.' Tariff rates as of June 2026 are assumed to persist all year.
Debt Paydown Continues, Leverage Path Intact but Tight
Total debt is down $155M YoY to $716M, net leverage sits at 3.48x, and cash flow remains explicitly prioritized for debt reduction. The credit agreement's covenant ceiling steps down from 4.50x to 3.50x from August 2027, so the company's ~3.2x year-end target isn't aspirational — it's required headroom. That's why the negative Q1 operating cash flow deserves more attention than the income statement.
Other KPIs
Stable but stubborn. Leverage peaked at 3.77x in 26Q3, and despite $82M of asset-sale proceeds applied to debt, it has only improved to 3.48x — because trailing EBITDA ($199.7M per credit agreement) is barely growing. The path to the ~3.2x year-end target runs entirely through back-half EBITDA delivery, not further asset sales.
Down 110bps YoY. The trend over five quarters is a steady grind lower (47.1% → 44.2% → 46.9% → 44.6% → 46.0% on a Q1-comparable basis, 47.1% a year ago). Decelerating erosion, but still erosion — tariffs, inventory obsolescence and customer mix remain net headwinds, and the new commodity/freight pressures in the outlook suggest no near-term relief.
Down 11% YoY from $13.8M on lower average borrowings — one of the few clean, mechanical benefits of the debt paydown flowing straight to EPS. Full-year guidance of $45.5-47.5M implies continued sequential decline and is slightly better than the $47-49M guided a quarter ago.
Down 3.5% YoY ($484.1M), consistent with the stated working-capital emphasis on inventory reduction — but the balance now carries approximately $15M of capitalized incremental tariff costs that will flow through cost of goods sold in coming quarters, a pre-loaded gross margin headwind.
Guidance
Raised from the prior $1.751-$1.822B range. Midpoint implies +0.5% YoY — but after Q1's +8.2%, the remaining nine months imply roughly -1.5% at midpoint versus the prior-year period. Decelerating, and sharply: management is telling you Q1's growth rate does not persist once the easy tariff-disruption comps are lapped. Segment guidance embeds a notable asymmetry — Home & Outdoor guided up ~4.6% for the year while Beauty & Wellness is guided down ~3.1% despite growing 7% in Q1.
Midpoint $3.50 versus FY26's $3.54 — flat to slightly down, unchanged despite the sales raise. That combination is an implicit margin guide-down, attributed to commodity, freight and currency costs. With Q1 at $0.17, the remaining nine months must deliver $3.08-$3.58 versus $3.13 in the comparable prior-year period — essentially flat, which is plausible but leaves no room for error given ~95% of the year is still ahead.
Flat versus FY26's $185.8M at the low end, +6% at the high end. Two caveats: the guide now includes a one-time $9.2M Phase 1 tariff refund (future refund phases excluded), meaning underlying EBITDA expectations effectively declined ~5%; and the remaining nine-month requirement of $164-172M compares to $160.3M in the prior-year period — modest growth required, but from a quarter that just printed flat EBITDA YoY ($25.5M both years).
Maintained despite Q1's -$6.4M — meaning the remaining nine months must generate $91-106M, versus $87M in the comparable prior-year period. Achievable if the working-capital reversal management expects materializes (inventory reduction is an explicit emphasis), but this target now carries more back-half risk than it did a quarter ago, and it is the number the leverage covenant story depends on.
Unchanged target, from 3.48x today. The math requires both the FCF target (applied to debt) and the EBITDA target to land. Miss either, and the company faces the August 2027 covenant step-down to 3.50x with thin headroom — the repeat-amendment scenario.
Key Questions
Olive & June: Distribution or Velocity?
Nail care again led Beauty & Wellness, but the release attributes it to 'new and expanded distribution' with no organic growth number disclosed. How much of the growth is door-count (CVS, Walmart) versus same-door velocity — and what happens when the distribution runway is filled?
The Cash Flow Bridge
Operating cash flow was negative $0.6M in Q1, yet the full-year target of $119-130M is maintained. What is the quarter-by-quarter working capital path — and how much of the FY27 cash tariff burden (FY26's was ~$72M) is embedded?
B&W Margin Recovery Mechanics
Beauty & Wellness adjusted operating margin fell to 1.8% while the segment grew 7%. What specifically bridges this segment back to profitability — pricing flow-through, tariff refunds, mix — and why is full-year segment revenue guided down ~3% after a +7% start?
China COGS Milestone Progress
The release is silent on supply-chain diversification progress. Where does China COGS exposure stand today versus the ~30% at FY26 year-end and the 15-20% target for FYE FY27, and is dual-sourcing on track from 45% toward 55%?
Commodity Cost Quantification
Middle East-driven commodity and freight inflation has moved from 'too new to model' into the outlook. What dollar headwind is now embedded, and how much incremental pricing — beyond the ~$50M already landed — would further escalation require?